Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Murphy

Showing results (441-450 of 643) with videos related to

Pageof 65
Sort By:
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in ratsC S Aulakh, J Zohar, K M Wozniak, et al.
Neuropharmacology|October 1, 1979
Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brainD S Robinson, I C Campbell, M Walker, et al.
Journal of Abnormal Psychology|July 15, 2000
Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approachN B Schmidt, J Storey, B D Greenberg, et al.
Biological Psychiatry|April 1, 1993
Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controlsJ R Joseph-Vanderpool, F M Jacobsen, D L Murphy, et al.
European Journal of Pharmacology|May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the ratR M Cohen, I C Campbell, I Yamaguchi, et al.
Archives of General Psychiatry|August 1, 1986
Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of dosesP N Tariot, T Sunderland, H Weingartner, et al.
Journal of Clinical Psychopharmacology|February 1, 1992
A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, F L'Heureux, J L Hill, et al.
Psychopharmacology Bulletin|January 1, 1985
Low- and high-dose naloxone in dementia of the Alzheimer typeP N Tariot, T Sunderland, H Weingartner, et al.
Clinical Pharmacology and Therapeutics|February 1, 1977
Reduction in plasma norepinephrine during fenfluramine treatmentC E de la Vega, S Slater, M G Ziegler, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1989
Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in ratsC S Aulakh, M Haass, J Zohar, et al.
Pageof 65

Showing results (441-450 of 643) with videos related to

Sort By:
Pageof 65
Pharmacology, Biochemistry, and Behavior|May 1, 1991
Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in ratsC S Aulakh, J Zohar, K M Wozniak, et al.
Neuropharmacology|October 1, 1979
Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brainD S Robinson, I C Campbell, M Walker, et al.
Journal of Abnormal Psychology|July 15, 2000
Evaluating gene x psychological risk factor effects in the pathogenesis of anxiety: a new model approachN B Schmidt, J Storey, B D Greenberg, et al.
Biological Psychiatry|April 1, 1993
Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controlsJ R Joseph-Vanderpool, F M Jacobsen, D L Murphy, et al.
European Journal of Pharmacology|May 7, 1982
Cardiovascular changes in response to selective monoamine oxidase inhibition in the ratR M Cohen, I C Campbell, I Yamaguchi, et al.
Archives of General Psychiatry|August 1, 1986
Naloxone and Alzheimer's disease. Cognitive and behavioral effects of a range of dosesP N Tariot, T Sunderland, H Weingartner, et al.
Journal of Clinical Psychopharmacology|February 1, 1992
A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, F L'Heureux, J L Hill, et al.
Psychopharmacology Bulletin|January 1, 1985
Low- and high-dose naloxone in dementia of the Alzheimer typeP N Tariot, T Sunderland, H Weingartner, et al.
Clinical Pharmacology and Therapeutics|February 1, 1977
Reduction in plasma norepinephrine during fenfluramine treatmentC E de la Vega, S Slater, M G Ziegler, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1989
Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in ratsC S Aulakh, M Haass, J Zohar, et al.
Pageof 65